A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer with SOX Plus Tislelizumab Combined with HIPEC
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs Tislelizumab (Primary) ; Gimeracil/oteracil/tegafur; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 13 Jan 2025 New trial record